Improving Lives Through Research®

Public Health

Pandemics. Opioid overdoses. Diabetes. Obesity. Depression. These are among the top public health challenges that influence the research of our premier interdisciplinary public health professionals and epidemiologists. Fueled by our evidence-based research approach on preventing, diagnosing, and treating infectious and chronic diseases and other conditions, 365体育亚洲唯一官方入口 works to support our clients in finding ways to determine how best to protect and improve the health of affected populations and society at large.

Our research enables our clients to make revolutionary medical advances—developing and tracking the effectiveness of new vaccines, therapies, and medicines for a healthier world. 365体育亚洲唯一官方入口 provides expertise in surveillance, program interventions, communication, and evaluation. We apply our knowledge, continually demonstrating our ability to quickly adjust to unforeseen research challenges and our commitment to absolute transparency.

Featured

See how we can answer questions like...

Does cancer screening save lives?

What are the current feeding practices of infants and toddlers?

See More Projects

Public Health Leadership

Patricia Shifflett
Patricia Shifflett
Vice President & Sector Lead, Health
Jennifer Kuo
Jennifer Kuo
Vice President & Practice Director

Meet our Experts

360+

Projects

160

Staff

200

Recent Publications

News

Data Collection & Survey Research

DAWN Releases Report on Non-Fatal Overdoses

Public Health

Jennifer Kuo to Become 365体育亚洲唯一官方入口’s New Public Health Practice Director

Data Collection & Survey Research

Drug Abuse Warning Network (DAWN) 2021 Final Findings Released

See More News

Publications

Sugarbaker P.H., Chang D., and Liang J.J. (2023).

ASO author reflections: Similar survival of all subtypes of mucinous appendiceal adenocarcinoma except the intermediate subtype which shows an improved survival.

Annals of Surgical Oncology, 30(3), 1886-1888.
DOI | PubMed
Nelson A.T., Harris A.K., Watson D., Miniati D., Finch M., Kamihara J., Mitchell S.G., Wilson D.B., Gettinger K., Rangaswami A.A., Campos J.M., Lederman S., Feltis B.A., Vasta L.M., Harney L.A., Stewart D.R., Dehner L.P., Messinger Y.H., Hill D.A., and Schultz K.A.P. (2023).

Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.

Cancer, 129(4), 600-613.
DOI | PubMed
Shrine N., Izquierdo A.G., Chen J., Packer R., Hall R.J., Guyatt A.L., Batini C., Thompson R.J., Pavuluri C., Malik V., Hobbs B.D., Moll M., Kim W., Tal-Singer R., Bakke P., Fawcett K.A., John C., Coley K., Piga N.N., Pozarickij A., Lin K., Millwood I.Y., Chen Z., Li L., Wijnant S.R.A., Lahousse L., Brusselle G., Uitterlinden A.G., Manichaikul A., Oelsner E.C., Rich S.S., Barr R.G., Kerr S.M., Vitart V., Brown M.R., Wielscher M., Imboden M., Jeong A., Bartz T.M., Gharib S.A., Flexeder C., Karrasch S., Gieger C., Peters A., Stubbe B., Hu X., Ortega V.E., Meyers D.A., Bleecker E.R., Gabriel S.B., Gupta N., Smith A.V., Luan J., Zhao J.H., Hansen A.F., Langhammer A., Willer C., Bhatta L., Porteous D., Smith B.H., Campbell A., Sofer T., Lee J., Daviglus M.L., Yu B., Lim E., Xu H., O'Connor G.T., Thareja G., Albagha O.M.E., Suhre K., Granell R., Faquih T.O., Hiemstra P.S., Slats A.M., Mullin B.H., Hui J., James A., Beilby J., Patasova K., Hysi P., Koskela J.T., Wyss A.B., Jin J., Sikdar S., Lee M., May-Wilson S., Pirastu N., Kentistou K.A., Joshi P.K., Timmers P., Williams A.T., Free R.C., Wang X., Morrison J.L., Gilliland F.D., Chen Z., Wang C.A., Foong R.E., Harris S.E., Taylor A., Redmond P., Cook J.P., Mahajan A., Lind L., Palviainen T., Lehtimäki T., Raitakari O.T., Kaprio J., Rantanen T., Pietiläinen K.H., Cox S.R., Pennell C.E., Hall G.L., Gauderman W.J., Brightling C., Wilson J.F., Vasankari T., Laitinen T., Salomaa V., Mook-Kanamori D.O., Timpson N.J., Zeggini E., Dupuis J., Hayward C., Brumpton B., Langenberg C., Weiss S., Homuth G., Schmidt C.O., Probst-Hensch N., Jarvelin M.R., Morrison A.C., Polasek O., Rudan I., Lee J.H., Sayers I., Rawlins E.L., Dudbridge F., Silverman E.K., Strachan D.P., Walters R.G., Morris A.P., London S.J., Cho M.H., Wain L.V., Hall I.P., and Tobin M.D. (2023).

Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk.

Nature Genetics, 55(3), 410-422.
DOI | PubMed

See More Publications

Want to work with us?
You’ll be in great company.

About Us Careers

365体育亚洲唯一官方入口 Employees.
365体育亚洲唯一官方入口 Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
SiriusXM
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
Toyota
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2023 Best Employers for Diversity Powered by Statista Forbes 2023 America's Best Mid-Size Employers Powered by Statista Forbes 2022 The Best Employers for Women Powered by Statista

365体育亚洲唯一官方入口 is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.